Financial Results : Saudi German Health makes SAR 264.1M profit in 9M 2025, SAR 40.3M in Q3

Saudi German Health makes SAR 264.1M profit in 9M 2025, SAR 40.3M in Q3

02/11/2025 Argaam Exclusive

View other reports

Middle East Healthcare Co. (Saudi German Health) posted net earnings of SAR 264.1 million for the first nine months of 2025, up from SAR 170.7 million in the year before.



Financials (M)

Item 9m 2024 9m 2025 Change‬
Revenues 2,133.94 2,293.84 7.5 %
Gross Income 831.82 875.64 5.3 %
Operating Income 339.24 300.33 (11.5 %)
Net Income 170.71 264.09 54.7 %
Average Shares 92.04 92.04 -
Earnings Per Share before unusual items (Riyals) 1.64 1.63 (0.8 %)
EPS (Riyal) 1.85 2.87 54.7 %

Elevated revenues mainly lifted the Saudi-listed company’s nine-month profit increase during the current period, supported by growth in the total number of inpatient admissions and outpatient visits, as well as the expansion of bed capacity across selected facilities within the group.

 

The company also benefited from an exceptional contract awarded by the Ministry of Health to operate Mina Emergency Hospital II during the 2025 Hajj season. This is besides lower finance costs due to improved leverage and declining interest rates.



Current Quarter Comparison (M)

Compared With The
Item Q3 2024 Q3 2025 Change‬
Revenues 732.07 768.97 5.0 %
Gross Income 292.90 283.95 (3.1 %)
Operating Income 115.88 87.44 (24.5 %)
Net Income 63.84 40.29 (36.9 %)
Average Shares 92.04 92.04 -
Earnings Per Share before unusual items (Riyal) 0.69 0.44 (36.9 %)
EPS (Riyal) 0.69 0.44 (36.9 %)

Moreover, in 9M 2025, Saudi German Health generated a one-off capital gain of SAR 114 million from the sale of an unused land plot in Riyadh, compared to a capital gain of SAR 19.6 million recorded last year.

 

However, the Saudi healthcare provider’s net profits tumbled by 36.9% to SAR 40.3 million in Q3 2025, versus SAR 63.84 million in the same quarter last year.

 

This quarterly earnings drop was mainly attributed to higher operating costs and increased staff expenses resulting from new hires linked to capacity expansion across several branches and the introduction of new subspecialties across various departments.

 

General, selling, and marketing expenses also rose following the implementation of the “NPHIES” system for Ministry of Health billing starting April 2025, while the company also recorded a higher share of losses from an associate, Al-Sobh New Medical Co., which is 22.4% owned by the group, after it commenced operations on Sept. 15.

 

This was partly offset by higher revenues during the quarter, supported by increased inpatient and outpatient volumes and expanded bed capacity in selected facilities.

 

On a quarterly basis, the three-month bottom line shrank from SAR 63.67 million in Q2 2025.

 

Total shareholders' equity, after minority interest, reached SAR 1.84 billion by the end of Sept. 30, 2025, edging up from SAR 1.49 billion a year earlier.

 

View more financial results

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.